☆ 4.8 Letter

Breast-Cancer Predisposition in Multiple Endocrine Neoplasia Type 1

NEW ENGLAND JOURNAL OF MEDICINE (2014)

期刊

NEW ENGLAND JOURNAL OF MEDICINE

卷 371, 期 6, 页码 583-584

出版社

MASSACHUSETTS MEDICAL SOC

DOI: 10.1056/NEJMc1406028

关键词

-

类别

Medicine, General & Internal

资金

NIDDK NIH HHS [R01 DK100584, R01DK100584] Funding Source: Medline

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Endocrinology & Metabolism

Clinical aspects of multiple endocrine neoplasia type 1

Abdallah Al-Salameh, Guillaume Cadiot, Alain Calender, Pierre Goudet, Philippe Chanson

Summary: Multiple endocrine neoplasia type 1 (MEN1) is a rare syndrome characterized by the co-occurrence of primary hyperparathyroidism, duodenopancreatic neuroendocrine tumours (NETs) and/or pituitary adenomas. Patients with MEN1 should undergo tailored biochemical and imaging screening. Knowledge about the clinical phenotype of these tumours has progressed over the past 10 years, particularly in France and the Netherlands.

NATURE REVIEWS ENDOCRINOLOGY (2021)

添加到收藏夹

Article Oncology

Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs)

Grigoris Effraimidis, Ulrich Knigge, Maria Rossing, Peter Oturai, Ase Krogh Rasmussen, Ulla Feldt-Rasmussen

Summary: Neuroendocrine neoplasms (NENs) are rare tumors that have shown a significant increase in incidence over the past four decades. These tumors arise from neuroendocrine cells and have diverse presentations and behaviors, depending on the organ involved. Multiple endocrine neoplasia type 1 (MEN-1) is a key genetic syndrome associated with NENs and research on diagnosis and treatment is progressing.

SEMINARS IN CANCER BIOLOGY (2022)

添加到收藏夹

Review Endocrinology & Metabolism

Expressions of Cushing's syndrome in multiple endocrine neoplasia type 1

William F. Simonds

Summary: Cushing's syndrome can occur spontaneously or in the context of familial disease. Multiple endocrine neoplasia type 1 (MEN1) is unique among familial endocrine tumor syndromes as it can result in hypercortisolism due to pituitary, adrenal, or thymic neuroendocrine tumors. The clinical manifestations of MEN1 include primary hyperparathyroidism, pituitary tumors, gastroenteropancreatic neuroendocrine tumors, and bronchial carcinoid tumors. CS in MEN1 can be caused by ACTH-secreting pituitary tumors, adrenocortical neoplasms, or ectopic tumoral ACTH secretion from thymic neuroendocrine tumors.

FRONTIERS IN ENDOCRINOLOGY (2023)

添加到收藏夹

Article Genetics & Heredity

Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors

Antongiulio Faggiano, Beatrice Fazzalari, Nevena Mikovic, Flaminia Russo, Virginia Zamponi, Rossella Mazzilli, Vito Guarnieri, Maria Piane, Vincenzo Visco, Simona Petrucci

Summary: The aim of this study was to evaluate the predictive role of specific clinical factors for the diagnosis of MEN1 and MEN4 in patients with an initial diagnosis of gastrointestinal, bronchial, or thymic neuroendocrine tumor (NET). The preliminary data showed that a diagnosis of NET in patients with a negative family history may suggest MEN1 in the presence of >= three positive phenotypic criteria.

GENES (2023)

添加到收藏夹

Article Medicine, General & Internal

Parathyroid disorder and concomitant thyroid cancer in patients with multiple endocrine neoplasia type 1 A retrospective cohort study

Ying Wang, Sheng Cai, He Liu, Rui-Na Zhao, Xing-Jian Lai, Ke Lv, Yu-Xin Jiang, Jian-Chu Li

Summary: Patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism (MPHP) had higher levels of parathyroid hormone, more frequent multiglandular parathyroid disease and hyperplasia, and parathyroid lesions usually presented with a round shape on ultrasonography compared to those with sporadic primary hyperparathyroidism (SPHP). Over the last 5 years, more concurrent thyroid cancer was found in MPHP patients than in SPHP patients.

MEDICINE (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status

Kuan-Yu Lin, Yu-Ting Kuo, Mei-Fang Cheng, Pei-Lung Chen, Hsiu-Po Wang, Tsu-Yao Cheng, Chia-Hsuin Chang, Hsiang-Fong Kao, Shih-Hung Yang, Hung-Yuan Li, Chia-Hung Lin, Yuh-Tsyr Chou, An-Ko Chung, Wan-Chen Wu, Jin-Ying Lu, Chih-Yuan Wang, Wen-Hui Hsih, Chen-Yu Wen, Wei-Shiung Yang, Shyang-Rong Shih

Summary: Recent studies suggest that the clinical characteristics and biological behavior of pituitary tumors in patients with MEN1 may be less aggressive than previously reported. Increased imaging of the pituitary as recommended by screening guidelines identifies more tumors potentially at an earlier stage. However, it is unknown if these tumors have different clinical characteristics in different MEN1 mutations.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

添加到收藏夹

Article Medicine, General & Internal

A case report of multiple endocrine neoplasia type 1 and autoimmune disease Coincidence or correlation?

Carolina Chaves, Tiago Nunes da Silva, Bernardo Dias Pereira, Joao Anselmo, Isabel Claro, Branca M. Cavaco, Ana Saramago, Valeriano Leite

Summary: MEN1 is a familial syndrome caused by disruption of the MENIN tumor suppressor protein, leading to challenges in management due to its effects on various endocrine tissues and predisposition to tumors. This case presented a patient with multiple endocrine and autoimmune disorders, underwent surgical interventions and long-term familial genetic screening, resulting in stable outcomes during a 24-year follow-up period. The interplay between MENIN and the immune system highlighted in this case may have implications for future targeted surveillance and treatment of MEN1 patients.

MEDICINE (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1

Francesca Marini, Francesca Giusti, Francesco Tonelli, Maria Luisa Brandi

Summary: Pancreatic neuroendocrine tumors (pNETs) are a rare group of cancers, accounting for about 1-2% of all pancreatic neoplasms, with some arising in patients with endocrine tumor syndromes such as Multiple Endocrine Neoplasia type 1 (MEN1). MEN1-related pNETs present challenges in treatment due to their unique characteristics and the need for extensive surgery. Epigenetic-based therapies aiming to correct DNA methylation and histone modifications may offer a potential therapeutic strategy for MEN1 pNETs resistant to standard treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice

Dirk-Jan van Beek, Carolina R. C. Pieterman, Frank J. Wessels, Annenienke C. van de Ven, Wouter W. de Herder, Olaf M. Dekkers, Wouter T. Zandee, Madeleine L. Drent, Peter H. Bisschop, Bas Havekes, Inne H. M. Borel Rinkes, Menno R. Vriens, Gerlof D. Valk

Summary: This study aimed to assess the diagnostic accuracy of conventional pancreatic imaging techniques and the added value of fine needle aspirations (FNA) in diagnosing MEN1-related pancreatic neuroendocrine tumors (PanNETs). MRI was found to have higher accuracy than CT in diagnosing PanNETs, making it the preferred non-invasive imaging modality. The high diagnostic accuracy of pancreatic imaging and the sporadic occurrence of pancreatic adenocarcinoma raise questions about the need for routine FNA.

FRONTIERS IN ENDOCRINOLOGY (2022)

添加到收藏夹

Article Oncology

Multiple endocrine neoplasia type 1 involving both the liver and lung: a case report

Jianlin Lai, Yangyang Huang, Junyi Wu, Hui Cheng, Funan Qiu

Summary: This case report describes a patient with MEN1 who had simultaneous liver and lung involvement and achieved good outcomes with surgical treatment. The study suggests a possibility of MEN1-associated diseases occurring in the liver and other nonendocrine organs, but further verification is needed.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Article Genetics & Heredity

Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China

Yuan Zhao, Jie Yu, Yiwen Liu, Lu Lyu, Fan Ping, Lingling Xu, Wei Li, Ou Wang, Qiang Xu, Wenming Wu, Huabing Zhang, Yuxiu Li

Summary: The study found that patients with MEN1-related insulinoma and high serum calcium levels may have altered insulin secretion. Postoperative recurrence rates and long-term complications were significantly different in these patients.

ORPHANET JOURNAL OF RARE DISEASES (2022)

添加到收藏夹

Article Pathology

Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome

Anna Vera D. Verschuur, Aranxa S. M. Kok, Folkert H. M. Morsink, Wendy W. J. de Leng, Medard F. M. van den Broek, Marco J. Koudijs, Johan A. Offerhaus, Gerlof D. Valk, Menno R. Vriens, Bernadette P. M. van Nesselrooij, Wenzel M. Hackeng, Lodewijk A. A. Brosens

Summary: A clinical diagnosis of multiple endocrine neoplasia type 1 (MEN1) syndrome is usually confirmed with genetic testing in the germline. This study investigated the potential of menin immunohistochemistry in parathyroid adenomas as an additional tool in the recognition and genetic diagnosis of MEN1 syndrome. Menin loss was found in 100% of patients with MEN1 and 9% of patients without MEN1, indicating the usefulness of menin immunohistochemistry in identifying MEN1-related tumors. It also showed high positive and negative predictive values for the diagnosis of MEN1.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2023)

添加到收藏夹

Article Endocrinology & Metabolism

Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1

Isabella Santiago de Melo Miranda, Luciana Pinto Valadares, Gustavo Barcelos Barra, Pedro Goes Mesquita, Lidiana Bandeira de Santana, Lucas Faria de Castro, Ticiane Henriques Santa Rita, Luciana Ansaneli Naves

Summary: This study conducted a retrospective analysis of 500 medical records from the Neuroendocrinology Outpatient Clinic of the University Hospital of Brasilia, and identified 4 families with MEN1 syndrome. Variants in the MEN1 gene were found in all 11 patients from these families. The findings contribute to the understanding of genetic and phenotypic characteristics of MEN1 patients in Brasilia.

FRONTIERS IN ENDOCRINOLOGY (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy

Francesca Marini, Maria Luisa Brandi

Summary: Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant inherited multiple cancer syndrome, with a complex pathogenesis involving genetic factors, epigenetic factors, and other exogenous and endogenous factors. The microRNA miR-24 may play a significant role in the occurrence and development of MEN1 syndrome.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Review Rheumatology

Multiple endocrine neoplasia type 1 revealed by a hip pathologic fracture

Maroua Slouma, Maissa Abbes, Rim Dhahri, Noureddine Litaiem, Nour Gueddiche, Nada Mansouri, Issam Msekni, Imen Gharsallah, Leila Metoui, Bassem Louzir

Summary: Multiple endocrine neoplasia type 1 is a rare genetic syndrome that primarily affects endocrine tissues and has significant impact on the skeletal system. When pathological fractures occur in young patients, consideration should be given to diagnosis of this disease. Early intervention and treatment are crucial in preventing further skeletal damage.

CLINICAL RHEUMATOLOGY (2021)

添加到收藏夹

Review Endocrinology & Metabolism

Glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence?

Kristina Laugesen, Leonie H. A. Broersen, Simon Boggild Hansen, Olaf M. Dekkers, Henrik Toft Sorensen, Jens Otto L. Jorgensen

Summary: Glucocorticoids are widely used anti-inflammatory medications, but can lead to adrenal insufficiency with varying risk and course among patients. Further research is needed to investigate risk factors, clinical implications, and predictors of glucocorticoid-induced adrenal insufficiency.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Multiple testing: when 's many too much?

Rolf H. H. Groenwold, Jelle J. Goeman, Saskia Le Cessie, Olaf M. Dekkers

Summary: In medical research, the testing of multiple hypotheses raises the risk of false-positive conclusions. Methods to mitigate this risk are discussed.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size

Wenzel M. Hackeng, Lodewijk A. A. Brosens, Joo Young Kim, Roderick O'Sullivan, You-Na Sung, Ta-Chiang Liu, Dengfeng Cao, Michelle Heayn, Jacqueline Brosnan-Cashman, Soyeon An, Folkert H. M. Morsink, Charlotte M. Heidsma, Gerlof D. Valk, Menno R. Vriens, Els Nieveen van Dijkum, G. Johan A. Offerhaus, Koen M. A. Dreijerink, Herbert Zeh, Amer H. Zureikat, Melissa Hogg, Kenneth Lee, David Geller, J. Wallis Marsh, Alessandro Paniccia, Melanie Ongchin, James F. Pingpank, Nathan Bahary, Muaz Aijazi, Randall Brand, Jennifer Chennat, Rohit Das, Kenneth E. Fasanella, Asif Khalid, Kevin McGrath, Savreet Sarkaria, Harkirat Singh, Adam Slivka, Michael Nalesnik, Xiaoli Han, Marina N. Nikiforova, Rita Teresa Lawlor, Andrea Mafficini, Boris Rusev, Vincenzo Corbo, Claudio Luchini, Samantha Bersani, Antonio Pea, Sara Cingarlini, Luca Landoni, Roberto Salvia, Massimo Milione, Michele Milella, Aldo Scarpa, Seung-Mo Hong, Christopher M. Heaphy, Aatur D. Singhi

Summary: Recent studies have shown that ATRX/DAXX and ALT are important prognostic factors for NF-PanNETs, especially in tumors less than or equal to 2.0 cm. These biomarkers are highly specific for pancreatic origin among NET metastases of unknown primary.

GUT (2022)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

Using electronic health record data for clinical research: a quick guide

Sophie H. Bots, Rolf H. H. Groenwold, Olaf M. Dekkers

Summary: This article discusses the challenges and limitations of using Electronic Health Record (EHR) data for research, and provides suggestions on how to deal with these challenges. It serves as a quick guide for researchers interested in EHR-based research.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

添加到收藏夹

Review Oncology

Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors

Koen M. A. Dreijerink, Wenzel M. Hackeng, Aatur D. Singhi, Christopher M. Heaphy, Lodewijk A. A. Brosens

Summary: NF-PanNETs are a heterogeneous group of neuroendocrine tumors with highly variable clinical behavior, necessitating improved prognostic biomarkers and molecular profiling. NF-PanNETs displaying alpha cell characteristics are more likely to present unfavorable biomarkers, while those with beta cell characteristics often lack these markers.

JOURNAL OF PATHOLOGY (2022)

添加到收藏夹

Review Public, Environmental & Occupational Health

How measurements affected by medication use are reported and handled in observational research: A literature review

Jungyeon Choi, Olaf M. Dekkers, Saskia le Cessie

Summary: Many studies in observational research fail to handle medication use properly, and a significant number of studies use invalid methods to handle medication use.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

添加到收藏夹

Article Oncology

Health-Related Quality of Life in Adrenocortical Carcinoma: Development of the Disease-Specific Questionnaire ACC-QOL and Results from the PROFILES Registry

Rebecca Steenaard, Thomas M. A. Kerkhofs, Myrte Zijlstra, Floortje Mols, Michiel N. Kerstens, Henry J. L. M. Timmers, Rachel S. van Leeuwaarde, Koen M. A. Dreijerink, Elisabeth M. W. Eekhoff, Els J. M. Nieveen van Dijkum, Eleonora P. M. Corssmit, Ellen Kapiteijn, Marjolein N. T. Kremers, Richard A. Feelders, Harm R. Haak

Summary: This study included the first assessment of health-related quality of life in patients with adrenocortical carcinoma. It found that patients diagnosed more than 5 years ago had relatively good HRQoL with residual fatigue and emotional problems. Patients who underwent additional surgery or received mitotane or chemotherapy reported lower HRQoL and problems in various domains.

CANCERS (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation

Vera H. W. van der Endt, Jet Milders, Bas B. L. Penning de Vries, Serge A. Trines, Rolf H. H. Groenwold, Olaf M. Dekkers, Marco Trevisan, Juan J. Carrero, Merel van Diepen, Friedo W. Dekker, Ype de Jong

Summary: This study systematically reviewed and assessed the validity, updates, and methodological quality of multiple risk scores to predict ischemic stroke in patients with atrial fibrillation. The newer risk scores showed better discriminatory abilities, but further external validations and data on calibration are needed before considering their use in clinical practice.

EUROPACE (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients

Pia Burman, Jacqueline Trouillas, Marco Losa, Ann McCormack, Stephan Petersenn, Vera Popovic, Marily Theodoropoulou, Gerald Raverot, Olaf M. Dekkers

Summary: This study describes the characteristics and treatment outcomes of aggressive pituitary tumors (APT) and pituitary carcinomas (PC). Temozolomide is the first-line chemotherapy, but other therapies are also emerging. Predicting treatment response remains challenging with current biomarkers.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Pleomorphic Ventricular Tachycardia in Dilated Cardiomyopathy Predicts Ventricular Tachycardia Recurrence After Ablation Independent From Cardiac Function: Comparison With Patients With Ischemic Heart Disease

Yoshitaka Kimura, Marta de Riva, Micaela Ebert, Claire Glashan, Adrianus P. Wijnmaalen, Sebastiaan R. Piers, Olaf M. Dekkers, Serge A. Trines, Katja Zeppenfeld

Summary: In dilated cardiomyopathy (DCM), pleomorphic VT (PL-VT) is not associated with mortality but predicts VT recurrence independent from LVEF, indicating a specific arrhythmic substrate difficult to control by current ablation techniques. In ischemic heart disease (IHD), PL-VT is associated with low LVEF and mortality.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Tying research question and analytical strategy when variables are affected by medication use

Jungyeon Choi, Olaf M. Dekkers, Saskia le Cessie

Summary: Ill-defined research questions can cause problems in epidemiological studies where measurements are subject to fluctuations due to events like medication use. Failing to specify how medication use should be handled during analysis can lead to arbitrary decisions and a disconnect between the intended question and analysis, resulting in different or meaningless interpretations of effects. This study discusses the formulation of well-defined research questions when medication use is involved, distinguishing between scenarios where exposure or outcome is affected by medication use and addressing methodological considerations under each question.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2023)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

Venous Thromboembolism and Gender-Affirming Hormone Therapy: A Reappraisal of Risks and Benefits

Koen M. A. Dreijerink

ENDOCRINE PRACTICE (2023)

添加到收藏夹

Article Dermatology

Skin cancer incidence in transgender individuals receiving gender-affirming hormone treatment: a nationwide cohort study in the Netherlands

Amirun Rahmat, Iris De Nie, Chantal M. Wiepjes, Martin Den Heijer, Thomas Rustemeyer, Christel J. M. De Blok, Koen M. A. Dreijerink

Summary: This study aimed to determine the incidence of skin cancer in transgender individuals receiving gender-affirming hormone treatment (GAHT). The results showed that GAHT did not appear to affect skin cancer incidence in this large cohort of transgender individuals.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2023)

添加到收藏夹

Article Psychology, Clinical

Tailored Gender-Affirming Hormone Treatment in Nonbinary Transgender Individuals: A Retrospective Study in a Referral Center Cohort

Josianne B. van Dijken, Thomas D. Steensma, Sarah Annelijn Wensing-Kruger, Martin den Heijer, Koen M. A. Dreijerink

Summary: This study found differences in hormone treatment between nonbinary and binary transgender individuals. Nonbinary individuals were more likely to receive tailored treatment. Further research is needed to explore individualized endocrine counseling and treatment regimens for nonbinary individuals.

TRANSGENDER HEALTH (2023)

添加到收藏夹

Review Endocrinology & Metabolism

Neuropsychiatric Adverse Effects of Synthetic Glucocorticoids: A Systematic Review and Meta-Analysis

Anne-Sophie C. A. M. Koning, Merel van der Meulen, Daphne Schaap, Djaina D. Satoer, Christiaan H. Vinkers, Elisabeth F. C. van Rossum, Wouter R. van Furth, Alberto M. Pereira, Onno C. Meijer, Olaf M. Dekkers

Summary: The proportion of neuropsychiatric adverse effects in patients using synthetic glucocorticoids is high, with depression and mania being the most significant associations. Awareness of possible psychiatric side effects is essential when starting glucocorticoid treatment.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.